• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在肿瘤内注射CpG ODN后,细胞因子和趋化因子在大小不同的小鼠结肠26肿瘤中的表达水平各异。

Cytokines and chemokines are expressed at different levels in small and large murine colon-26 tumors following intratumoral injections of CpG ODN.

作者信息

Sharma Sanjay, Karakousis Constantine P, Takita Hiroshi, Shin Kyu, Brooks Stephen P

机构信息

Department of Surgery, SUNY Buffalo and Kaleida Health, Buffalo General Hospital, Buffalo, NY 14203, USA.

出版信息

Neoplasia. 2004 Sep-Oct;6(5):523-8. doi: 10.1593/neo.04166.

DOI:10.1593/neo.04166
PMID:15548360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1531655/
Abstract

Direct tumor injections of (CpG ODN) into murine colon tumor 26 (CT-26) tumors can induce a potent antitumor response. Tumor size at the beginning of treatment determines the final therapeutic outcome, with smaller tumors responding favorably to CpG ODN therapy whereas large tumors do not. CpG ODN injections in small tumors resulted in tumor necrosis and extensive inflammatory cell infiltration, with average survival that is significantly higher (48.1 +/- 34 days) when compared to control ODN-treated mice (16.1 +/- 3.5 days). Cytokines and chemokines are expressed at different levels in small and large CT-26 tumors following intratumoral injections of CpG ODN. We observed that granulocyte-macrophage colony-stimulating factor and interleukin (IL) 6 are the major cytokines that were overexpressed in CpG ODN-treated small tumors but not in large tumors. Similarly, several chemokines (CXCL1, CCL2, and CCL3) were also significantly higher in CpG ODN-treated small tumors compared to control ODN-treated tumors.

摘要

将(CpG寡脱氧核苷酸)直接注射到小鼠结肠肿瘤26(CT - 26)肿瘤中可诱导强大的抗肿瘤反应。治疗开始时的肿瘤大小决定最终治疗结果,较小的肿瘤对CpG寡脱氧核苷酸治疗反应良好,而大肿瘤则不然。在小肿瘤中注射CpG寡脱氧核苷酸导致肿瘤坏死和广泛的炎性细胞浸润,与对照寡脱氧核苷酸处理的小鼠(16.1±3.5天)相比,平均生存期显著更长(48.1±34天)。在肿瘤内注射CpG寡脱氧核苷酸后,细胞因子和趋化因子在大小不同的CT - 26肿瘤中表达水平不同。我们观察到,粒细胞巨噬细胞集落刺激因子和白细胞介素(IL)6是在CpG寡脱氧核苷酸处理的小肿瘤中过度表达但在大肿瘤中未过度表达的主要细胞因子。同样,与对照寡脱氧核苷酸处理的肿瘤相比,几种趋化因子(CXCL1、CCL2和CCL3)在CpG寡脱氧核苷酸处理的小肿瘤中也显著更高。

相似文献

1
Cytokines and chemokines are expressed at different levels in small and large murine colon-26 tumors following intratumoral injections of CpG ODN.在肿瘤内注射CpG ODN后,细胞因子和趋化因子在大小不同的小鼠结肠26肿瘤中的表达水平各异。
Neoplasia. 2004 Sep-Oct;6(5):523-8. doi: 10.1593/neo.04166.
2
Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif.含GTCGTT基序的CpG寡脱氧核苷酸(ODN 2059)对牛B淋巴细胞、单核细胞和巨噬细胞中白细胞介素-6和白细胞介素-12的诱导作用。
J Interferon Cytokine Res. 2001 Oct;21(10):871-81. doi: 10.1089/107999001753238123.
3
Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapy.基于树突状细胞和CpG寡核苷酸的联合免疫疗法可治愈抵抗化疗的大型鼠类肿瘤。
Eur J Immunol. 2002 Nov;32(11):3235-45. doi: 10.1002/1521-4141(200211)32:11<3235::AID-IMMU3235>3.0.CO;2-J.
4
Two distinct pathways of immuno-modulation improve potency of p53 immunization in rejecting established tumors.两种不同的免疫调节途径可提高p53免疫在排斥已形成肿瘤方面的效力。
Cancer Res. 2004 Aug 1;64(15):5407-14. doi: 10.1158/0008-5472.CAN-04-0169.
5
CpG oligonucleotides: novel regulators of osteoclast differentiation.CpG寡核苷酸:破骨细胞分化的新型调节因子。
FASEB J. 2002 Mar;16(3):274-82. doi: 10.1096/fj.01-0586com.
6
CpG oligodeoxynucleotides induce murine macrophages to up-regulate chemokine mRNA expression.CpG寡脱氧核苷酸诱导小鼠巨噬细胞上调趋化因子mRNA表达。
Cell Immunol. 2000 Dec 15;206(2):101-6. doi: 10.1006/cimm.2000.1735.
7
[Antitumor effect of CpG oligonucleotides on human neuroblastoma xenografts in nude mice].[CpG寡核苷酸对裸鼠人神经母细胞瘤异种移植瘤的抗肿瘤作用]
Ai Zheng. 2009 Apr;28(4):344-9.
8
Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.用CpG寡脱氧核苷酸靶向Toll样受体9可增强人肺癌患者外周血单个核细胞的抗肿瘤反应。
Cancer Invest. 2008 Jun;26(5):448-55. doi: 10.1080/07357900701681608.
9
CpG oligonucleotide therapy cures subcutaneous and orthotopic tumors and evokes protective immunity in murine bladder cancer.CpG寡核苷酸疗法可治愈皮下和原位肿瘤,并在小鼠膀胱癌中激发保护性免疫。
J Immunother. 2005 Jan-Feb;28(1):20-7. doi: 10.1097/00002371-200501000-00003.
10
CpG-ODN inhibits airway inflammation at effector phase through down-regulation of antigen-specific Th2-cell migration into lung.CpG寡脱氧核苷酸通过下调抗原特异性Th2细胞向肺内的迁移,在效应阶段抑制气道炎症。
Int Immunol. 2008 Feb;20(2):259-66. doi: 10.1093/intimm/dxm138. Epub 2007 Dec 21.

引用本文的文献

1
Responsive probes for in vivo magnetic resonance imaging of nitric oxide.用于一氧化氮体内磁共振成像的响应性探针。
Nat Mater. 2025 Jan;24(1):133-142. doi: 10.1038/s41563-024-02054-0. Epub 2024 Nov 25.
2
Toll-Like Receptors and the Response to Radiotherapy in Solid Tumors: Challenges and Opportunities.Toll样受体与实体瘤放疗反应:挑战与机遇
Vaccines (Basel). 2023 Apr 7;11(4):818. doi: 10.3390/vaccines11040818.
3
Tumor-derived granzyme B-expressing neutrophils acquire antitumor potential after lipid A treatment.肿瘤来源的表达颗粒酶B的中性粒细胞在脂多糖处理后获得抗肿瘤潜能。
Oncotarget. 2018 Jun 19;9(47):28364-28378. doi: 10.18632/oncotarget.25342.
4
Inhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll-like receptor agonists.腺相关病毒癌胚抗原疫苗与 Toll 样受体激动剂抑制和促进肿瘤生长。
Cancer Gene Ther. 2011 Dec;18(12):850-8. doi: 10.1038/cgt.2011.54. Epub 2011 Aug 26.
5
Gene expression down-regulation in CD90+ prostate tumor-associated stromal cells involves potential organ-specific genes.CD90+前列腺肿瘤相关基质细胞中的基因表达下调涉及潜在的器官特异性基因。
BMC Cancer. 2009 Sep 8;9:317. doi: 10.1186/1471-2407-9-317.
6
A review of the past, present, and future directions of neoplasia.肿瘤形成的过去、现在及未来发展方向综述。
Neoplasia. 2005 Dec;7(12):1039-46. doi: 10.1593/neo.05793.

本文引用的文献

1
Intratumoral injection of GM-CSF in perspective - a review.瘤内注射粒细胞-巨噬细胞集落刺激因子的前景——综述
J Med. 2003;34(1-6):149-53.
2
Of mice and not men: differences between mouse and human immunology.论小鼠而非人类:小鼠与人类免疫学的差异
J Immunol. 2004 Mar 1;172(5):2731-8. doi: 10.4049/jimmunol.172.5.2731.
3
Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides.用CpG寡脱氧核苷酸刺激Toll样受体9的抗肿瘤应用。
Curr Oncol Rep. 2004 Mar;6(2):88-95. doi: 10.1007/s11912-004-0019-0.
4
TLR9 signals after translocating from the ER to CpG DNA in the lysosome.TLR9从内质网转运至溶酶体中的CpG DNA后发出信号。
Nat Immunol. 2004 Feb;5(2):190-8. doi: 10.1038/ni1028. Epub 2004 Jan 11.
5
Cytokines in cancer pathogenesis and cancer therapy.细胞因子在癌症发病机制和癌症治疗中的作用
Nat Rev Cancer. 2004 Jan;4(1):11-22. doi: 10.1038/nrc1252.
6
IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2.白细胞介素-2瘤内免疫疗法增强介导肿瘤细胞和肿瘤相关血管破坏的CD8 + T细胞:白细胞介素-2的一种新机制。
J Immunol. 2003 Nov 15;171(10):5051-63. doi: 10.4049/jimmunol.171.10.5051.
7
Chemokines in cancer.
Expert Rev Mol Med. 2001 Jul 18;3(19):1-18. doi: 10.1017/S1462399401003301.
8
Intratumor CpG-oligodeoxynucleotide injection induces protective antitumor T cell immunity.肿瘤内注射CpG寡脱氧核苷酸可诱导保护性抗肿瘤T细胞免疫。
J Immunol. 2003 Oct 15;171(8):3941-6. doi: 10.4049/jimmunol.171.8.3941.
9
In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene delivery.通过肿瘤内递送粒细胞-巨噬细胞集落刺激因子(GM-CSF)基因原位招募抗原呈递细胞。
Cancer Immunol Immunother. 2004 Jan;53(1):17-25. doi: 10.1007/s00262-003-0417-4. Epub 2003 Sep 2.
10
Intra-tumoral injection of CpG results in the inhibition of tumor growth in murine Colon-26 and B-16 tumors.肿瘤内注射CpG可抑制小鼠结肠26和B - 16肿瘤的生长。
Biotechnol Lett. 2003 Jan;25(2):149-53. doi: 10.1023/a:1021927621813.